Exploring Risk and Protective Factors in Parkinson’s Disease

Understanding the risk and protective factors associated with Parkinson’s disease (PD) is crucial for improving outcomes for patients, individuals at risk, healthcare providers, and healthcare systems. Studying these factors not only enhances our knowledge of the disease but also aids in developing...

Full description

Saved in:
Bibliographic Details
Main Author: Iman Beheshti
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/10/710
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850258009781960704
author Iman Beheshti
author_facet Iman Beheshti
author_sort Iman Beheshti
collection DOAJ
description Understanding the risk and protective factors associated with Parkinson’s disease (PD) is crucial for improving outcomes for patients, individuals at risk, healthcare providers, and healthcare systems. Studying these factors not only enhances our knowledge of the disease but also aids in developing effective prevention, management, and treatment strategies. This paper reviews the key risk and protective factors associated with PD, with a particular focus on the biological mechanisms underlying these factors. Risk factors include genetic mutations, racial predispositions, and environmental exposures, all of which contribute to an increased likelihood of developing PD or accelerating its progression. Conversely, protective factors, such as regular physical exercise, adherence to a Mediterranean diet, and higher urate levels, have the potential to reduce inflammation and support mitochondrial function, thereby mitigating the risk of disease. However, identifying and validating these factors presents significant challenges. These challenges include the absence of reliable biomarkers, intricate interactions between genetic and environmental components, and clinical heterogeneity observed in patients with PD. These barriers complicate the establishment of clear causal relationships and hinder the development of targeted preventive strategies. To overcome these challenges, we propose several solutions and recommendations. Understanding the mechanisms underlying risk factors may inform future research aimed at developing standardized and more accurate biomarkers for PD, facilitating earlier diagnosis and improved monitoring of disease progression. Additionally, we offer actionable recommendations for PD prevention and management tailored to healthy individuals, patients diagnosed with PD, and healthcare systems. These strategies aim to improve clinical outcomes, enhance the quality of life, and optimize healthcare delivery for PD.
format Article
id doaj-art-53bcd9acbb694f8dab477778947c92d8
institution OA Journals
issn 2073-4409
language English
publishDate 2025-05-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj-art-53bcd9acbb694f8dab477778947c92d82025-08-20T01:56:16ZengMDPI AGCells2073-44092025-05-01141071010.3390/cells14100710Exploring Risk and Protective Factors in Parkinson’s DiseaseIman Beheshti0Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, University of Manitoba, 745 Bannatyne Ave., Winnipeg, MB R3E 0J9, CanadaUnderstanding the risk and protective factors associated with Parkinson’s disease (PD) is crucial for improving outcomes for patients, individuals at risk, healthcare providers, and healthcare systems. Studying these factors not only enhances our knowledge of the disease but also aids in developing effective prevention, management, and treatment strategies. This paper reviews the key risk and protective factors associated with PD, with a particular focus on the biological mechanisms underlying these factors. Risk factors include genetic mutations, racial predispositions, and environmental exposures, all of which contribute to an increased likelihood of developing PD or accelerating its progression. Conversely, protective factors, such as regular physical exercise, adherence to a Mediterranean diet, and higher urate levels, have the potential to reduce inflammation and support mitochondrial function, thereby mitigating the risk of disease. However, identifying and validating these factors presents significant challenges. These challenges include the absence of reliable biomarkers, intricate interactions between genetic and environmental components, and clinical heterogeneity observed in patients with PD. These barriers complicate the establishment of clear causal relationships and hinder the development of targeted preventive strategies. To overcome these challenges, we propose several solutions and recommendations. Understanding the mechanisms underlying risk factors may inform future research aimed at developing standardized and more accurate biomarkers for PD, facilitating earlier diagnosis and improved monitoring of disease progression. Additionally, we offer actionable recommendations for PD prevention and management tailored to healthy individuals, patients diagnosed with PD, and healthcare systems. These strategies aim to improve clinical outcomes, enhance the quality of life, and optimize healthcare delivery for PD.https://www.mdpi.com/2073-4409/14/10/710Parkinson’s diseaserisk factorssymptomgeneticsbiological mechanisms
spellingShingle Iman Beheshti
Exploring Risk and Protective Factors in Parkinson’s Disease
Cells
Parkinson’s disease
risk factors
symptom
genetics
biological mechanisms
title Exploring Risk and Protective Factors in Parkinson’s Disease
title_full Exploring Risk and Protective Factors in Parkinson’s Disease
title_fullStr Exploring Risk and Protective Factors in Parkinson’s Disease
title_full_unstemmed Exploring Risk and Protective Factors in Parkinson’s Disease
title_short Exploring Risk and Protective Factors in Parkinson’s Disease
title_sort exploring risk and protective factors in parkinson s disease
topic Parkinson’s disease
risk factors
symptom
genetics
biological mechanisms
url https://www.mdpi.com/2073-4409/14/10/710
work_keys_str_mv AT imanbeheshti exploringriskandprotectivefactorsinparkinsonsdisease